Bill
Bill > S3384
summary
Introduced
03/03/2020
03/03/2020
In Committee
03/03/2020
03/03/2020
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
Makes a series of changes to requirements relating to prescription drug prices. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs under the Medicare prescription drug benefit, allows individuals to import certain drugs from Canada to fill personal prescriptions, and establishes specific enforcement actions against patent infringement agreements that involve generic drug manufacturers and have anticompetitive effects.
AI Summary
This bill makes a series of changes to requirements relating to prescription drug prices under Medicare Part D. It requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain covered drugs, allows individuals to import certain drugs from Canada, establishes enforcement actions against patent infringement agreements that have anticompetitive effects, and increases the use of real-time benefit tools to lower beneficiary costs. The bill also redesigns the Medicare Part D benefit structure, including reducing beneficiary coinsurance, decreasing reinsurance payment amounts, and establishing a manufacturer discount program during the initial and catastrophic phases of coverage.
Committee Categories
Budget and Finance
Sponsors (1)
Last Action
Read twice and referred to the Committee on Finance. (on 03/03/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/senate-bill/3384/all-info |
| BillText | https://www.congress.gov/116/bills/s3384/BILLS-116s3384is.pdf |
| Bill | https://www.congress.gov/116/bills/s3384/BILLS-116s3384is.pdf.pdf |
Loading...